Literature DB >> 3484357

Myasthenia gravis: population differences in disease expression and acetylcholine receptor antibody titers between Chinese and Caucasians.

H C Chiu1, A Vincent, J Newsom-Davis, K H Hsieh, T Hung.   

Abstract

Clinical features and anti-acetylcholine receptor (AChR) titers were compared in Chinese (n = 258) and Caucasian (n = 258) myasthenia gravis populations. The former had more early onset and ocular cases, lacked the Caucasian late onset peak, and had fewer severe cases. The distribution of anti-AChR titers was broadly similar in the two populations, and their sera reacted equally well with AChR in both races. The significantly lower (chi 2 = 14.6; p less than 0.001) median anti-AChR titer in the Chinese population can be accounted for by the higher frequency of ocular cases and lower frequency of moderate or severely affected cases.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3484357     DOI: 10.1212/wnl.37.12.1854

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

1.  Immunoglobulin heavy chain gene associations in myasthenia gravis: new evidence for disease heterogeneity.

Authors:  A Demaine; N Willcox; M Janer; K Welsh; J Newsom-Davis
Journal:  J Neurol       Date:  1992-01       Impact factor: 4.849

2.  Nationwide population-based epidemiological study of myasthenia gravis in taiwan.

Authors:  Chien-Hsu Lai; Hung-Fu Tseng
Journal:  Neuroepidemiology       Date:  2010-06-03       Impact factor: 3.282

3.  Possible distinct pathogenesis in low responder myasthenia gravis: association of soluble interleukin-2 receptor with acetylcholine receptor antibody titre or abnormal thymus.

Authors:  M Hayashi; K Kida; J Yoshinaga
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-08       Impact factor: 10.154

4.  The high frequency and clinical feature of seronegative myasthenia gravis in Southern China.

Authors:  Hui-Yu Feng; Hai-Yan Wang; Wei-Bin Liu; Xue-Tao He; Xin Huang; Chuan-Ming Luo; Yan Li
Journal:  Neurol Sci       Date:  2012-07-25       Impact factor: 3.307

5.  Association of HLA-Bw46DR9 combination with juvenile myasthenia gravis in Chinese.

Authors:  W H Chen; H C Chiu; R P Hseih
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-04       Impact factor: 10.154

6.  A cohort study on myasthenia gravis patients in China.

Authors:  Wei Wang; Yu-Ping Chen; Zhong-Kui Wang; Dong-Ning Wei; Ling Yin
Journal:  Neurol Sci       Date:  2013-02-20       Impact factor: 3.307

7.  The MGTX experience: challenges in planning and executing an international, multicenter clinical trial.

Authors:  Inmaculada B Aban; Gil I Wolfe; Gary R Cutter; Henry J Kaminski; Alfred Jaretzki; Greg Minisman; Robin Conwit; John Newsom-Davis
Journal:  J Neuroimmunol       Date:  2008-09-15       Impact factor: 3.478

Review 8.  Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity.

Authors:  Matthew N Meriggioli; Donald B Sanders
Journal:  Lancet Neurol       Date:  2009-05       Impact factor: 44.182

9.  Myasthenia gravis, paraneoplastic pemphigus and thymoma, a rare triade.

Authors:  D T Winkler; P Strnad; M L Meier; S Roten; P Went; P Lyrer; A J Steck
Journal:  J Neurol       Date:  2007-08-03       Impact factor: 4.849

10.  Racial differences in myasthenia gravis in Alabama.

Authors:  Shin J Oh; Marla B Morgan; Liang Lu; Yuki Hatanaka; Shoji Hemmi; Angela Young; Gwendolyn C Claussen
Journal:  Muscle Nerve       Date:  2009-03       Impact factor: 3.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.